Mountain Valley MD (CSE: MVMD- OTCQB: MVMDF) CEO Dennis Hancock and Director of Life Sciences Dr. Mike Farber joined Steve Darling to discuss the company being able to achieve a water solubilized selamectin product using its patent-pending Quicksol technology. Hancock talks about this breakthrough and why they have filed a patent for this, while Dr. Farber says he believes this is a critical achievement to allow formulation into topical application creams, oral rapid dissolve sublingual tablets, and injectable applications.
Mountain Valley MD takes major step forward achieving Solubilization of Selamectin
